Pierre Hainaut

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

103h-index44.9kcitations745works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(231), Epigenetics and DNA Methylation(129), Cancer Genomics and Diagnostics(92), RNA modifications and cancer(77), Lung Cancer Treatments and Mutations(55)

Publications740 total

Figure 6 from SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2025Open Access
Figure 1 from SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2025Open Access
Figure 3 from SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2025Open Access
Figure 4 from SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2025Open Access
Figure 5 from SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2025Open Access
Figure 2 from SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2025Open Access
Figure 7 from SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
2025Open Access
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
EBioMedicine·2025Open Access
Simultaneous exogenous application of trans-zeatin riboside and EDDS: A powerful strategy to improve heavy metals phytoextraction efficiency by Miscanthus x giganteus L
Chemosphere·2025Open Access
Transfer Learning for Survival-based Clustering of Predictors with an Application to <i>TP53</i> Mutation Annotation
2025Open Access
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational study
European Journal of Cancer·2025
TP53 variant clusters stratify phenotypic diversity in germline carriers and reveal an osteosarcoma-prone subgroup
Nature Communications·2025· 1 citedOpen Access
Tumor Patterns and Cancer Risk in Carriers of <i>TP53</i> exonic Germline Variants that alter mRNA Splicing
2025Open Access
Missense but mis-spliced: germline <i>TP53</i> variant c.671A&gt;C (p.E224A) and the path from uncertainty to pathogenicity
2025· 1 citedOpen Access
Author Correction: Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms
npj Systems Biology and Applications·2025Open Access
Neoantigenic properties of <i>TP53</i> variants modify cancer risk in individuals with Li-Fraumeni syndrome
2025Open Access
The metabolic kinase LKB1 shapes the enteric nervous system by mitigating the oxidative stress and p53 activity
2025Open Access
Transcriptional regulation by LKB1 in lung adenocarcinomas: Exploring oxidative stress, neuroglial and amino acid signatures
Biochemical and Biophysical Research Communications·2025· 2 cited
Personalized screening strategies for TP53 R337H carriers: a retrospective cohort study of tumor spectrum in Li-Fraumeni syndrome adult carriers
The Lancet Regional Health - Americas·2025· 3 citedOpen Access
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Thrombosis and Haemostasis·2025· 1 citedOpen Access
page 1 of 37Next →

Frequent Co-authors

Magali Olivier(11), Monica Hollstein(5), Paolo Boffetta(4), Elio Ríboli(4), Paul Brennan(4), Ruggero Montesano(4), Amelie Plymoth(3), Rayjean J. Hung(3), Давид Заридзе(3), Françoise Clavel‐Chapelon(3), Paolo Vineis(3), Anne Tjønneland(3), Kim Overvad(3), Salvatore Panico(3), Domenico Palli(3), ­Rosario ­Tumino(3), G. Hallmans(3), Amina Amadou(2), Audrey Petitjean(2), Shunsuke Kato(2)